BioCentury
ARTICLE | Distillery Therapeutics

Cancer

May 31, 2017 4:32 PM UTC

Patient sample, cell culture and mouse studies identified a nucleoside analog that could help treat primary effusion lymphoma (PEL) and MM. High throughput screening of a small molecule library in cel...

BCIQ Company Profiles

Weill Cornell Medicine

BCIQ Target Profiles

Adenosine kinase